New treatment offers dogs year-round protection with a single shot.
New treatment offers dogs year-round protection with a single shot.Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday.
The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The treatment is approved for dogs and puppies 6 months and older. The new shot is an alternative to treatments that usually need to be given every month or every few months."Fluralaner, the active ingredient in Bravecto Quantum, can be an important part of parasite control depending on where pet owners live in the country," said Dr. Tina Wismer, senior director of toxicology at ASPCA Poison Control, in an email to ABC News. "A long-term flea and tick preventative can be a useful option for dog owners who live in areas where year-round protection is necessary, or for those who might not be able or remember to administer treatment on a monthly or quarterly basis."The injectable treatment must be administered by a licensed veterinarian, who will determine whether an 8- or 12-month protection period is appropriate based on local tick species. Veterinarians will also monitor for potential side effects. While the drug belongs to a commonly used and safe class of medications called isoxazolines, some dogs may experience neurologic side effects, including muscle tremors and seizures. Julie Cappiello, with Voters For Animal Rights, an advocacy organization, said she welcomes the new treatment but emphasized caution. "As someone who spends a great deal of time outdoors with my dog, I see the convenience of a long-lasting, 12-month flea and tick preventative like Bravecto Quantum," she said in a statement. "However, it's important to recognize that no single treatment is right for every dog, and all medications come with potential risks."Pet owners interested in the new treatment option should consult their veterinarians to determine if it's appropriate for their dogs, particularly those with a history of neurological issues.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves New 3-in-1 Combo Pill for High Blood PressureThe FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.
Read more »
FDA Approves New Antibody Shot To Protect Infants Against RSVMerck's preventive antibody shot, Enflonsia, should be available to protect infants, regardless of weight, from RSV in the coming 2025-2026 cold season.
Read more »
New Balance’s Coolest New Sneaker Looks Nothing Like a New Balance Sneaker'I really drew references from what the future looked like in the early 2000s, and I think it's still relevant now,' Lee told FN.
Read more »
State Department Reveals Changes for Student Visa ApplicantsThe new memo lifted a pause on new visa interviews, with new vetting requirements introduced.
Read more »
Epigenetic Clocks: New Types, New Promises, New SkepticismTests showing how fast we’re aging have undeniable research value, potential clinical uses, and predictable consumer appeal. But birthdays may not be obsolete just yet.
Read more »
New Trials, New Targets: New Hope for Alzheimer’sAfter decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and new therapeutic targets fueling cautious hope.
Read more »